Boric Acid in Modern Medicine: Properties, Antifungal Mechanisms, Clinical Uses, and Toxicity Profile

Boric acid exists as white crystalline granules or flakes exhibiting specific antimicrobial and biochemical dynamics:

• Lewis Acidity: H3BO3 acts as an electron pair acceptor, generating borate anions [B(OH)4]- in aqueous environments and buffering tissue surfaces to an acidic pH unfavorable to pathogens.
• Cellular Lysis: It readily diffuses across fungal and bacterial cell membranes, inhibiting oxidative phosphorylation and interfering with RNA-mediated protein synthesis.
• Astringent and Desiccant Action: When applied topically, dilute solutions induce superficial protein coagulation, reducing tissue edema and exuding moisture from acute weeping dermatitis.

Contemporary clinical protocols reserve boric acid for precise, targeted indications:

• Refractory Vulvovaginal Candidiasis: Intravaginal boric acid capsules (600 mg once daily at bedtime for 14 days) serve as the guideline-endorsed therapy for recurrent infections caused by non-albicans species (predominantly Candida glabrata).
• Superficial Dermatological Compresses: Diluted 1% to 3% aqueous solutions are utilized in moist dressings for acute inflammatory skin lesions, intertrigo, and weeping eczema.
• Otitis Externa Management: Boric acid in diluted alcohol drops assists in re-acidifying the external auditory canal and inhibiting otomycotic fungal colonization.

Boric acid carries a narrow margin of safety and can precipitate life-threatening systemic toxicity if misapplied:

• Absorption via Compromised Integument: Rapidly absorbed through open wounds, extensive burns, and denuded mucosal surfaces, boron accumulates within renal parenchymal and neural tissues.
• Strict Pediatric and Pregnancy Ban: Strictly contraindicated in infants and young children under 3 years of age, during pregnancy (documented embryotoxicity and teratogenicity), and in renal impairment.
• Exclusive External Route: Ingestion is strictly prohibited; accidental oral intake induces gastrointestinal hemorrhage, erythroderma, circulatory collapse, and acute tubular necrosis.

Overview of standardized pharmaceutical preparations and market availability:

• Aqueous Solutions (3% Acidum Boricum): Standard 100 ml to 500 ml bottles retail between £2.50 and £6.00 (€3–€7 / ~10–25 PLN) as economical topical antiseptics.
• Boric Ointments and Pastes: Topical formulations (e.g., 3% boric vaseline) range from £3.00 to £7.50 (€4–€9 / ~15–35 PLN) for targeted localized application.
• Compounded Vaginal Capsules: Customized 600 mg gelatin capsules prepared via compounding pharmacies for fungal eradication typically cost £14 to £28 (€18–€32 / ~65–125 PLN) per therapeutic cycle.